(c) 2024 PillSync.com

Australia Atomoxetine 25 mg

INDICATIONS & USAGE: hyperactive-impulsive or inattentive symptoms that cause impairment...ADHD...treatment of Attention-Deficit/Hyperactivity Disorder...increased the risk of suicidal ideation in short-term studies in children or adolescents...


11 months ago   blue capsule A925 Australia Atomoxetine 25 mg

blue capsule A925

11 months ago   blue capsule A925 Australia Atomoxetine 25 mg

blue capsule A925

Comments

Related Pills

atomoxetine 60 MG Oral Capsule

glenmark pharmaceuticals inc., usa

atomoxetine 25 MG Oral Capsule

dr. reddy's laboratories limited












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site